Edinburgh, United Kingdom

Janice MacKenzie Paterson

This inventor holds 2 USPTO granted patents. Top assignee: Medical Research Council. Active years: 2000-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Janice MacKenzie Paterson. Retrieved from https://idiyas.com/inventor/janice-mackenzie-paterson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2000-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Janice MacKenzie Paterson: Innovator in Medical Research

Introduction

Janice MacKenzie Paterson is a prominent inventor based in Edinburgh, GB. She has made significant contributions to the field of medical research, particularly in the area of adenylate cyclase.

Latest Patents

Janice holds 2 patents, with her latest innovations being "Human adenylate cyclase and use therefor" and "Calcineurin regulatable adenylate cyclase." These patents reflect her expertise and dedication to advancing medical science.

Career Highlights

Janice is affiliated with the Medical Research Council, where she has been instrumental in various research projects. Her work has garnered attention for its potential impact on understanding and treating medical conditions.

Collaborations

Janice has collaborated with notable professionals in her field, including her coworker Ferenc Antoni. These partnerships have enhanced her research and contributed to her success as an inventor.

Conclusion

Janice MacKenzie Paterson is a remarkable inventor whose work in medical research continues to influence the field. Her patents and collaborations highlight her commitment to innovation and scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…